Last reviewed · How we verify
Zihua Wenfei Zhisou Granule — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Zihua Wenfei Zhisou Granule (Zihua Wenfei Zhisou Granule) — DoCare Pharmaceutial Technology Co.,Ltd. Zihua Wenfei Zhisou Granule's mechanism is not publicly available.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Zihua Wenfei Zhisou Granule TARGET | Zihua Wenfei Zhisou Granule | DoCare Pharmaceutial Technology Co.,Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Zihua Wenfei Zhisou Granule CI watch — RSS
- Zihua Wenfei Zhisou Granule CI watch — Atom
- Zihua Wenfei Zhisou Granule CI watch — JSON
- Zihua Wenfei Zhisou Granule alone — RSS
Cite this brief
Drug Landscape (2026). Zihua Wenfei Zhisou Granule — Competitive Intelligence Brief. https://druglandscape.com/ci/zihua-wenfei-zhisou-granule. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab